DOCSLIB.ORG

Wednesday, January 08, 2020 Post-Graduate Day 14:00-14

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Wednesday, January 08, 2020 Post-Graduate Day 14:00-14 Program Legend: Hebrew Networking Event English Scheduled Break WEDNESDAY, JANUARY 08, 2020 POST-GRADUATE DAY 14:00-14:30 Light Buffet Lunch (Exhibition Area) HALL B HALL A SESSION 1 | Treat to target in CD-define your target SESSION 2 | Advances in Clinical Nutrition – Thinking Outside of the “Lunch 14:30-15:45 14:30-15:45 Sponsored by Takeda Box” Chairs: Revital Kariv, Tel Aviv Sourasky Medical Center and Irit Avni Biron, Rabin Chairs: Liat Deutsch, Tel Aviv Sourasky Medical Center and Sigal Frishman, Rabin Medical Center Medical Center 14:30-14:50 Complete Remission- How Deep Is Enough?: Ayal Hirsch, Tel Aviv Sourasky 14:30-14:55 Nutrigenetics - basic and practical concepts: Ruth Birk, Ariel University Medical Center 14:55-15:03 Abstract 3 14:50-15:10 Perianal Fistulas-Do We See The Light At The End Of The Tunnel?: Ian White, Milk derived exosomes has a therapeutic effect on experimental colitis: Rabin Medical Center and Doron Schwartz, Soroka Medical Center Regina Golan-Gerstl, Hadassah Medical Center 15:10-15:30 PROMs In IBD-Ready For Clinical Practice?: Mati Waterman, Rambam Health 15:03-15:11 Abstract 4 Care Campus Characteristics of patients referred for investigation of reflux: Yishai Ron, Tel Aviv Sourasky Medical Center 15:30-15:38 Abstract 1 Vedolizumab has similar efficacy and safety rates in young and elderly 15:11-15:19 Abstract 5 patients- a binational, multicenter, retrospective case-control study: Endoscopic gastro-jejunal anastomotic reduction after bariatric surgery Nathaniel Aviv Cohen, Tel Aviv University improves intractable dumping syndrome: Relly Reicher, Sourasky Medical Center 15:38-15:46 Abstract 2 a4β7 receptor occupancy by vedolizumab at trough time-point occurs at the 15:19-15:44 Intestinal transplantations: Eviatar Nesher, Rabin Medical Center membranal level and is not associated with endoscopic healing in ibd patients: Shomron Ben-Horin, Sheba Medical Center 15:45-16:05 Coffee Break (Exhibition Area) SESSION 3 | Malignancy Precision – Immunology, Genetics, and SESSION 4 | From epidemiology to Technology- Updates in 16:05-17:20 16:05-17:20 Surveillance Neurogastroenterology Chairs: Zohar Levi, Rabin Medical Center and Elizabeth Half, Rambam Health Care Chairs: Ram Dickman, Rabin Medical Center and Roy Dekel, Tel Aviv Sourasky Campus Medical Center 16:05-16:25 Appropriate surveillance intervals tailored by gene and the potential role of 16:05-16:30 Gastroparesis and functional dyspepsia: one and one equal one?: Yehuda enhanced endoscopy in Lynch Syndrome – the post graduate course talk: Uri Ringel, Meir Medical Center Ladabaum, Stanford University School of Medicine 16:30-16:50 EndoFLIP- The new player in esophageal motility testing: Daniel Pohl, 16:25-16:33 Abstract 6 University Hospital Zurich Proteomics portraits the immune landscape of msi-h colorectal tumors: Elez Vainer, Hadassah Medical Center 16:50-16:58 Abstract 8 Volumetric rectal sensation testing: is it clinically relevant? Results from a 16:33-16:58 Immunotherapy of cancer, successes, failures, and challenges: Ilan Volovitz, large patient cohort: Yoav Mazor, Rambam Health Care Campus Tel Aviv Sourasky Medical Center 16:58-17:18 IBS Global Survey: Ami Sperber, Ben-Gurion University of the Negev 16:58-17:06 Abstract 7 Juvenile polyposis syndrome in israel is associated with a high mutation detection rate: Lior Katz, Hadassah Medical Center 17:06-17:26 Current genetic analysis in colorectal cancer: Somatic and germline mutations: Fred Menko, Amsterdam University Medical Center 17:20-17:30 Technical Break HALL B 17:30-18:46 SESSION 5 | Double trouble: Cancer in IBD and IBD in Cancer Chairs: Rami Eliakim, Sheba Medical Center and David Rubin, University of Chicago 17:30-17:50 Advances in Dysplasia detection and management 2020: Ofer Ben Bassat, Barzilai University Medical Center 17:50-17:58 Abstract 9 Effectiveness of dose escalation in Crohn`s disease patients with insufficient response to standard-dose subcutaneous ustekinumab maintenance therapy - a multicenter European cohort study: Uri Kopylov, Tel Aviv University 17:58-18:18 Checkpoint inhibitor and colitis, lessons for IBD: Dror Shouval, Sheba Medical Center 18:18-18:26 Abstract 10 Thromboembolic events in hospitalized patients with inflammatory bowel disease – a large tertiary hospital experience: Asaf Levartovsky, Sheba Medical Center 18:26-18:46 The IBD patient with current/previous cancer: Hagar Banai, Rabin Medical Center and Lior Katz, Hadassah Medical Center 18:46 Drinks & Mingling (Exhibition Area) THURSDAY, JANUARY 09, 2020 07:30-08:30 Light Breakfast and Gathering (Exhibition Area) HALL B 08:30-10:15 SESSION 6 | Opening Session Chairs: Iris Dotan, Rabin Medical Center and Haim Shirin, Shamir Medical Center 08:30-08:45 Opening remarks: Iris Dotan, Rabin Medical Center 08:45-09:15 Positioning of old and new therapies in IBD- personalized decision making: David Rubin, University of Chicago* 09:15-09:45 CRC screening and post polypectomy surveillance strategies, updates and personalized screening: Uri Ladabaum, Stanford University School of Medicine 09:45-10:15 Targeting aging as a reversible disease: Shai Efrati, Shamir Medical Center *Sponsored by Pfizer 10:15-10:45 Coffee Break (Exhibition Area) HALL B HALL A HALL C HALL D SESSION 7 | Updates in Liver SESSION 8 | Performance אחיות | SESSION 10 10:45-12:15 אדמיניסטרציה | SESSION 9 10:45-12:15 10:45-12:15 10:45-12:15 and esophageal disease from Tests to Practice Chairs: Cheli Levin, Assuta Medical תניר ציון, מרכז רפואי רבין :Chairs: Rifaat Safadi, Hadassah Chairs: Ian Gralnek, HaEmek Chairs Medical Center and Haia Medical Center and Tova Center and Dganit Daniel Fainguelernt, Meir Medical Rainis, Bnai Zion Medical Avdar, Hadasssah Medical Center Center Center Updates and Innovations from 10:45-11:00 דברי פתיחה: איריס דותן, מרכז How to simplify treatment of 10:45-11:10 Investigating 10:45-10:55 10:45-11:10 ,ESGENA: Yuri Gurielm רפואי רבין HCV to the way of Gastroenterology patients elimination: Eli Zuckerman, for Pancreatic Exocrine Rambam Health Care Campus מטופלות מהמגזרים השונים Carmel Medical Center* Insufficiency: Miroslav 10:55-11:10 Transesophageal EUS-guided 11:00-11:15 בחברה הישראלית: אריאלה Vujasinovic, Karolinska coil: Violeta Gabovich, Rabin שטרית, מרכז רפואי שערי צדק **Abstract 11 University Hospital 11:10-11:18 Characterization of HDV, Medical Center דם סמוי בצואה: עפרה שרעבי, HBsAg and ALT kinetics under 11:10-11:18 Abstract 14 11:10-11:25 ESD: Amir Klein, Rambam 11:15-11:30 מרכז רפואי קפלן :Peginterferon-Lambda Premium non nocere Monotherapy: The Phase 2 endoscopic biliary stents for Health Care Campus קפסולה אנדוסקופית: עירית LIMT Study: David Yardeni, cholangitis complication 11:25-11:40 Management Endoscopic of 11:30-11:45 אבני, מרכז רפואי רבין Soroka Medical Center choledocholithiasis in the elderly are safe and can be Obesity: Steven Shamah, Rabin Medical Center תזונה כטיפול משלים ברפואה Provocation tests in left for up to 25 months: 11:40-11:55 11:18-11:33 המודרנית: ליהי גודני, מרכז esophageal motility: Why, Anas Kadah, Galilee Medical Should we always need to take 11:45-12:00 רפואי רבין which and when to use: Amir Center Mari, Nazareth Hospital preventive steps?: Shulamit לוגיסטיקה, חזון וחידושים: 11:18-11:33 ERCP 2020- Indications and 11:55-12:10 Monitin, Soroka Medical רויטל קריב, סוראסקי מרכז 11:33-11:41 Abstract 12 complications: Marianna Center רפואי תל אביב Lower vedolizumab trough Arvanitakis, ERCP levels before interval 12:00-12:15 “Holding it inside” isn’t the shortening are not predictive 11:33-11:41 Abstract 15 solution: Leonid Shpoker, Bnai of success of the intervention: Endoscopy and gender, Zion Medical Center Shomron Ben-Horin, Sheba similarities and differences: Medical Center Naim Abu Freha, Soroka Medical Center 11:41-11:49 Abstract 13 Neurtophil to lymphocyte 11:41-12:15 Better Endoscopic Training & ratio predicts progression to Practice – Tips and Tricks- high grade dysplasia and Ian Gralnek interviewing: esophageal adenocarcinoma Harold Jacob, Hadassah in patients with Barrett`s Medical Center, Donald esophagus: Noam Peleg, MacIntosh, Canada and Rabin Medical Center Jonathan Cohen, Lenox Hill Hospital *Sponsored by Gilead **Sponsored by Abbot 11:49-12:14 Eosinophilic Oesophagitis – A common Disease, new treatment options: Stephen Attwood, Durham University* 12:15-13:00 Lunch Break (Exhibition Area) SESSION 12 | The Fatty SESSION 11| Burning ואדמיניסטרציה | Liver & Marilyn Monroe: Is SESSION 13 13:00-14:15 questions in IBD 13:00-14:15 13:00-14:15 אחיות a Treatment for NASH Sponsored by Janssen Finally on the Horizon? Chairs: Ariela Shitrit, Shaare Zedek Chairs: Gil Ben Yakov, Sheba Chairs: Medical Center and Adar Medical Center and Michal Zinger, Hadassah Medical Cohen, Rabin Medical Center Center איך להיות מאושר במאה ה- Mechanisms of molecular 13:00-13:15 Advances in PBC and PSC: 13:00-14:15 :?21 13:00-13:30 אייל דורון, המרז הבינתחומי, resistance and predictors of Ehud Zigmond, Tel Aviv הרצליה ואוניברסיטת חיפה response to biological Sourasky Medical Center therapy in IBD: Raja Atreya, University Hospital Erlangen, 13:15-13:23 Abstract 18 Germany Acute or recent portal vein thrombosis in cirrhosis 13:30-14:00 Immunology and microbiome predicts a hidden or in IBD patients: Nitsan upcoming diagnosis of Maharshak, Tel Aviv Sourasky hepatocellular carcinoma: Medical Center Rifaat Safadi, Hadassah Medical Center 14:00-14:08 Abstract 16 Multi-omics analysis reveals 13:23-13:31 Abstract 19 specific bio-geograohical and Anti-mitochondrial functional characteristics in antibodies
Load more

Recommended publications
  • Scientific Program
    www.iscort.org.il Scientific Program 08.01.2019 - 12.01.2019, Eilat, Israel The Annual Meeting of The Israeli Society for Clinical Oncology and Radiation Therapy ISCORT wishes to express its gratitude to the following companies הוועדה המארגנת for their support of the 19th ISCORT Annual Meeting: Organizing Committee ISCORT 19 נשיא הכנס: :President פרופ׳ סלומון שטמר Platinum Sponsor Salomon M. Stemmer, MD Roche מזכירת הכנס: :Secretory ד״ר ולריה סמניסטי Gold Sponsor Valeria Semenysty, MD יו"ר הרדיותרפיה: :BMS Radiation Oncology Co-Chair פרופ׳ בן קורן MSD Ben W. Corn, MD הוועדה המדעית Silver Sponsor Scientific Committee ISCORT 19 Astellas יו"ר: פרופ׳ מיכל לוטם Astrazeneca Chairman: Michal Lotem, MD ד"ר אהרון אלון Boehringer Ingelheim Aaron Allen, MD ד"ר נועם אסנה Eli Lilly Noam Asna, MD ד"ר יאיר בר ISI Jair Bar, MD PhD ד"ר יהונתן כהן Novartis Yonathan Cohen, MD PhD פרופ׳ בן קורן Pfizer Ben W. Corn, MD ד"ר אלה עברון Rafa Ella Evron, MD ד"ר דניאלה כץ Daniela Katz, MD פרופ׳ גל מרקל Bronze Sponsor Gal Markel, MD PhD ד"ר אינה אוספובט AbbVie Inna Ospovat, MD ד"ר אביבית פאר Assuta Avivit Peer, MD ד"ר רות פרץ Bayer Ruth Perets, MD PhD Bolpharma ד"ר רפאל פפר Raphael Pfeffer, MD Dexcel Pharma ד"ר קרן רובינוב Keren Rouvinov, MD Isotopia ד"ר יקטרינה שולמן Katerina Shulman, MD Medison ד"ר אמיר זוננבליק Merck Amir Sonnenblick, MD ד"ר מרק ויגודה Nanostring Marc Wygoda, MD ד"ר אלונה זר Neopharm Alona Zer, MD ד"ר אביעד זיק Oncotest-Teva Aviad Zik, MD Perrigo החברה המארגנת Sanofi Organizing Company א.מ.
    [Show full text]
  • Around the Globe Israeli Medical Association No
    Around The Globe Israeli Medical Association No. 16 | June 2011 A word from the chairman Dear Friends, vices to those from evacuated areas who and opinions on professional issues as e are happy to present you had no access to medical care. well as on the unbalanced exposures and with another issue of ‘IMA I had the pleasure of travelling to discussions of political topics concerning around the Globe’ where the UK, and met our Jewish Medical As- Israel in the British scientific Journals. I Wyou can read about the work of the IMA sociation - UK Chapter. I met medical would like to thank the IMA UK Chapter in Israel and abroad. In February, the students affiliated with the IMA and re- for their generous hospitality during my IMA publically announced our launch viewed Neuroscience practice in Israel. time in London. of “a mission to save public medicine,” I attended an evening event hosted by I am excited to inform you that we demanding additional manpower, more Dr. David Katz, the executive chairman have been invited to present Israeli and beds in hospitals, and incentive pay to of the UK Chapter, which was attended Jewish Medicine at the European Par- draw more physicians to the periphery by the local IMA-WF committee group. liament this November. I would like to and to multiple specialties suffering Throughout the evening we discussed thank Dr. Willie Lipschutz, the executive from physician shortages. This struggle issues related to how Israeli medicine chairman of the Belgian Chapter of IMA- is for health and medicine in Israel and is portrayed in British medical journals, WF for organizing the event.
    [Show full text]
  • Dear Colleagues, It Is Our Pleasure to Invite You to the Annual Meeting Of
    Dear Colleagues, It is our pleasure to invite you to the Annual Meeting of the Israel Neurosurgical Society which will be held at the Galilion Hotel, Israel. Although the main focus of the meeting will be Brain Tumors, the organizers will be happy to consider interesting talks on related subjects. Confirmed speakers to date that will share their experiences and update us in the latest developments include: Prof. Volker A. Coenen Dept. of Stereotactic and Functional Neurosurgery, University of Freiberg; Neurosurgery Clinic, Freiberg, Germany Prof. Garth Rees Cosgrov Dept. of Neurological Surgery, Brigham and Women's Hospital, Boston, MA, USA Prof. Hans Henkes Neuroradiological Clinic, Katharinenhospital, Stuttgart, Germany Prof. Robert H. Rosenwasser Dept. of Neurological Surgery, Jefferson Hospital for Neuroscience, Philadelphia, PA, USA As in previous meetings, we hope that this event will provide the opportunity to reconnect and meet with colleagues and to strengthen professional and personal ties among our members. We hope that you will be able to join us. Sincerely, Prof. Yigal Shoshann Prof. Mony Benifla Dr. Racheli Grossman President Secretary Treasurer 1 TENTATIVE TIMETABLE Wednesday, May 13, 2020 Light Lunch Afternoon Sessions Dinner Evening Social Event Thursday, May 14, 2020 Morning Sessions Lunch Afternoon Sessions Dinner Evening Social Event Friday, May 15, 2020 Morning Sessions Afternoon Sessions End and Light Lunch Meeting Secretariat Target Conferences Ltd. PO Box 51227, Tel Aviv 6713818, Israel Tel: +972 3 5175150, Fax: +972 3 5175155 e-mail: [email protected] www.israelneurosurgery.com 2 SCIENTIFIC ADVISORY COMMITTEE ON FUNCTIONAL NEUROSURGERY AND EPILEPSY Zvi Israel - Lead Advisor Dept. of Neurosurgery, Hadassah Hebrew University Medical Center, Jerusalem Roberto Spiegelmann Dept.
    [Show full text]
  • Conference Time Table
    CONFERENCE TIME TABLE 6 April 7-8, 2019, Hilton Tel Aviv Hotel The 48th Annual Meeting of the Israel Endocrine Society PROGRAM AT A GLANCE Sunday, April 7, 2019 15:30-15:50 Coffee Break 07:30-08:30 Registration and Gathering 15:50-16:50 Meet the Expert Hall A Meet the Expert Hall B Novel Avenues in the Management of Endocrine Hypertension 08:30-10:00 Parallel Oral Presentations Congenital Adrenal Hyperplasia Felix Beuschlein Thyroid Reproduction Obesity, Metabolic Syndrome Nils P Krone University Hospital of Zurich Chairs: Dania Hirsch, Chairs: Talia Geva Eldar, Chairs: Yonit Marcus- Perlman, Sheffield, UK Carlos Benbassat Joseph Orly Rosane Abramof-Ness 16:50-17:30 IES Members General Assembly Hall A Hall A Hall B Hall C Executive Committee Report 10:00-10:20 Coffee Break Accountant Report 10:20-11:20 Poster Session Poster Hall Prize lectures Hall A 11:20-12:10 Chair: Avraham Karasik Lindner Prize, Eyal Robenshtok Chowers Prize, Yael Riahi Outstanding Community Physician Award, Elizabeta Baron Plenary lecture 1 Hall A Fat in the Blood, Fat in the Heart 12:10-13:00 Ira Goldberg, NYU School of Medicine, NYU Langone Health Chair: Hannah Kanety 13:00-14:00 Lunch 14:00-15:30 Parallel Symposia Symposium 1 Hall A Symposium 2 Hall B Congenital Adrenal Hyperplasia (CAH) Big Data – Digital Health in in 2019 Endocrinology Chairs: Naomi Weintrob, David Zangen Chairs: Moshe Phillip, Irit Hochberg 14:00-14:30 Nils P Krone Varda Shalev Molecular Pathogenesis of Rare Forms Big Data: From Research to Value of CAH Director of research and innovation institute Academic Unit of Child Health Maccabi and Morris Kahn.
    [Show full text]
  • The New Neonatal Care Center at Soroka Medical Center
    The New Neonatal Care Center at Soroka Medical Center 1 2 The New Neonatal Care Center at Soroka Medical Center The new Neonatal Care Center will serve all newborns in the Negev and provide full protection against missile attacks in accordance with the standards of the Home Front Command of the Israel Defense Forces. Soroka Medical Center: An Overview With 1,100 beds, Soroka Medical Center is among Israel’s largest and most advanced hospitals, and the country’s busiest. Soroka is the only major medical center in the entire Negev, serving a population of more than one million inhabitants, including 400,000 children, in a region that accounts for 60% of the country’s total land area. Soroka serves as the teaching hospital of both the Medical School of Ben-Gurion University, whose Faculty of Health Sciences is located on the hospital campus, and its Medical School for International Health. On par with leading international institutions, Soroka specializes in areas that include, for example, early detection and treatment of breast cancer using minimally invasive procedures; non-invasive removal of malignant tumors; trauma rehabilitation of children and adolescents; pediatric infectious diseases; and much more. Each year, excellent care is provided to more than 750,000 people at outpatient and clinic visits; 235,000 patients visit our Emergency Medicine Department (the busiest in the country); 80,000 inpatients fill our beds; over33 ,000 patients undergo surgery, and more than 17,000 babies are born. Soroka’s neonatal and pediatric departments provide family-centered intensive care with world-class survival rates. Soroka’s Trauma Unit is the largest and busiest in Israel, always on call, 24 hours a day, 365 days a year.
    [Show full text]
  • Scientific Program
    The 63th Annual Conference of the Israel Heart Society in association with the Israel Society of Cardiothoracic Surgery April 12-13 • 2016 • Tel Aviv, Israel SCIENTIFIC PROGRAM Paragon Israel (Dan Knassim) Paragon Tel/Fax:03-5767730/7 Israel (Dan Knassim) a Paragon Group Company [email protected] TUESDAY, APRIL 12, 2016 08:30-10:00 Interventional Cardiology I Hall A Chairs: Ariel Finkelstein, Ran Kornowski, Israel 08:30 Effect of Diameter of Drug-Eluting Stents Versus Bare-Metal Stents on Late Outcomes: a propensity score-matched analysis Amos Levi1,2, Tamir Bental1,2, Hana Veknin Assa1,2, Gabriel Greenberg1,2, Eli Lev1,2, Ran Kornowski1,2, Abid Assali1,2 1Cardiology, Rabin Medical Center, Israel 2Sackler Faculty of Medicine, Tel Aviv University, Israel 08:41 Percutaneous Valve-in-Valve Implantation for the Treatment of Aortic, Mitral and Tricuspid Structural Bioprosthetic Valve Degeneration Uri Landes1, Abid Assali1, Ram Sharoni1,2, Hanna Vaknin-Assa1, Katia Orvin1, Amos Levi1, Yaron Shapira1, Shmuel Schwartzenberg1, Ashraf Hamdan1, Tamir Bental1, Alexander Sagie1, Ran Kornowski1 1Department of Cardiology, Rabin Medical Center, Tel Aviv, Israel 2Department of Cardiac Surgery, Rabin Medical Center, Tel Aviv, Israel 08:52 Temporal Trends in Transcatheter Aortic Valve Implantation in Israel 2008-2014: Patient Characteristics, Procedural Issues and Clinical Outcome Uri Landes1, Alon Barsheshet1, Abid Assali1, Hanna Vaknin-Assa1, Israel Barbash3, Victor Guetta3, Amit Segev3, Ariel Finkelstein2, Amir Halkin2, Jeremy Ben-Shoshan2,
    [Show full text]
  • Curriculum Vitae Shay Schneider, M.D
    April, 2020 Curriculum Vitae Shay Schneider, M.D Name: Shay Schneider Date of birth: December 23, 1979 Place of birth: Tel Aviv, Israel Family status: Married +2 Telephone: +972-54-7685189 E mail: [email protected] CLINICAL EXPERIENCE Sep 2018-present: Senior staff member Otolaryngology department, Soroka University Medical Center, Beer Sheva, Israel. Sep 2018-Sep 2020: Clinical Fellow (Rhinology and skull base surgery), A.R.M, Center of Otolaryngology/ Head and Neck Surgery, Assuta Medical Center, Tel Aviv, Israel. Sep 2012-Sep 2018: Resident: Otolaryngology department, Soroka University Medical Center, Beer Sheva, Israel. Jan 2011 - Jan 2012: Rotating internship year: Training physician in internal medicine, general surgery, anesthesia and pediatrics units, Barzilai Medical Center in Ashkelon, Israel. Jun 2009 - Aug 2009: Clinical rotation in Otolaryngology, Shaare Zedek Medical Center in Jerusalem, Israel. ACADEMIC DEGREES 2016- present: Instructor, Faculty of Health Sciences, Ben Gurion University, Beer Sheva, Israel. 2004-2010: MD degree, Third Medical Faculty, Charles University in Prague (English program), Czech Republic. POST ACADEMIC COURSES Jan 2020: Baloon sinuplasty and Eustachian tuboplasty, Madeira, Portugal. Aug-Sep 2018: Observership, University of Texas MD Anderson Cancer Center, Houston, Texas. United States 2013-2018: School of Continuing Studies, Otolaryngology program, The Sackler Faculty of Medicine, Tel Aviv University, Israel. June 2017: Rhinoplasty course, Ziv Medical Center, Israel Feb 2017: 4th Annual OSAS International Surgery Course, Florida Hospital Nicholson Center & Florida Hospital Celebration Health, Celebration, United States. Feb 2017: Trans- oral laser surgery (TLS) course, Kaplan Medical Center. Sep 2016: Head and neck dissection course, Tel Aviv University. Oct 2014: Sedation course, Sheba Medical Center, Tel Aviv.
    [Show full text]
  • Antibiotic Treatment for Invasive Listeriosis and Patient
    Antibiotic treatment for invasive listeriosis and patient outcome: a retrospective cohort study Yaakov Dickstein1, Yonatan Oster2, Orit Shimon3, Lior Nesher4, Dafna Yahav3,5, Yonit Wiener-Well6, Regev Cohen7,8, Ronen Ben-Ami3,9, Miriam Weinberger3,10, Galia Rahav3,11, Yasmin Maor3,12, Michal Chowers3,13, Ran Nir-Paz2, Mical Paul1,8 1 Institute of Infectious Diseases, Rambam Health Care Campus, Haifa, Israel 2 Department of Clinical Microbiology and Infectious Diseases, Hadassah-Hebrew University Medical Center, Jerusalem, Israel 3 Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel 4 Infectious Disease Institute, Soroka Medical Center, Ben-Gurion University of the Negev, Beer Sheba, Israel 5 Infectious Diseases Unit, Rabin Medical Center, Beilinson hospital, Petah-Tikva, Israel 6 Infectious Disease Unit, Shaare Zedek Medical Center, Jerusalem, Israel 7 Infectious Diseases Unit, Sanz Medical Center–Laniado Hospital , Netanya, Israel 8 The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel 9 Infectious Diseases Unit, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel 10 Infectious Diseases Unit, Assaf Harofeh Medical Center, Zerifin, Israel 11 Infectious Disease Unit, Sheba Medical Center, Ramat Gan, Israel 12 Infectious Disease Unit, Wolfson Medical Center, Holon, Israel 13 Infectious Diseases Unit, Meir Medical Center, Kfar Saba, Israel Cumulative survival by treatment group Background: Current treatment started within 48 hours of culture recommendations for treatment of results and continued for a minimum duration invasive listeriosis suggest ampicillin- of 7 days. Patients who died within 48 hours of based therapy with the addition of an the index culture were excluded. The primary aminoglycoside. However, several outcome was 30-day all-cause mortality.
    [Show full text]
  • Prospective Longitudinal Trends in Body Composition and Clinical Outcomes 3 Years Following Sleeve Gastrectomy
    Obesity Surgery (2019) 29:3833–3841 https://doi.org/10.1007/s11695-019-04057-2 ORIGINAL CONTRIBUTIONS Prospective Longitudinal Trends in Body Composition and Clinical Outcomes 3 Years Following Sleeve Gastrectomy Shiri Sherf-Dagan1,2,3 & Shira Zelber-Sagi1,4 & Assaf Buch5,6 & Nir Bar1,2 & Muriel Webb1 & Nasser Sakran7,8,9 & Asnat Raziel7 & David Goitein2,7,10 & Andrei Keidar11 & Oren Shibolet1,2 Published online: 11 July 2019 # Springer Science+Business Media, LLC, part of Springer Nature 2019 Abstract Background and Aims Longitudinal assessment of body composition following bariatric surgery allows monitoring of health status. Our aim was to elucidate trends of anthropometric and clinical outcomes 3 years following sleeve gastrectomy (SG). Methods A prospective cohort study of 60 patients who underwent SG. Anthropometrics including body composition analysis measured by multi-frequency bioelectrical impedance analysis, blood tests, liver fat content measured by abdominal ultrasound and habitual physical activity were evaluated at baseline and at 6 (M6), 12 (M12), and 36 (M36) months post-surgery. Results Sixty patients (55% women, age 44.7 ± 8.7 years) who completed the entire follow-up were included. Fat mass (FM) was reducedsignificantly1yearpost-surgery(55.8±11.3to26.7±8.3kg;P < 0.001) and then increased between 1 and 3 years post- operatively, but remained below baseline level (26.7 ± 8.3 to 33.1 ± 11.1 kg; P < 0.001). Fat free mass (FFM) decreased significantly during the first 6 months (64.7 ± 14.3 to 56.9 ± 11.8 kg; P < 0.001), slightly decreased between M6 and M12 and then reached a plateau through M36.
    [Show full text]
  • The Peres Center for Peace, Tel-Aviv April 12Th, 2019
    April 12th, 2019 The Peres Center for Peace, Tel-Aviv BREAST CANCER INNOVATIONS The Israeli Society for Clinical Oncology and Radiation Therapy and Roche are Pleased to Invite You to an Enriching and Educating Meeting with our Distinguished Guest Speaker: Prof. Charles E. Geyer Please Send the Attached Registration Form to A.M Knasim No Later than April 1st 2019 E-mail: [email protected] Tel: 03-6081520 Fax: 03-6081522 Prof. Charles E. Geyer Friday, 12th April 2019 • Professor of Medicine 08:00-09:00 Welcome Reception • Harrigan, Haw, Luck Families Chair in Cancer Research 09:00-09:10 Opening Remarks • Virginia Commonwealth University, Massey Dr. Noa Efrat Ben-Baruch Cancer Center Head, Israeli Breast Cancer Group • Associate Director of Clinical Research Head, Department of Oncology Kaplan Medical Center Charles E. Geyer, Jr. is Professor of Medicine and the Harrigan, Haw, Luck Families Chair in Cancer Research at Virginia Commonwealth University Massey Chairmen: Dr. Georgeta Fried Cancer Center, an NCI-designated Cancer Center. He serves as Associate Director Head Breast Cancer Unit of Clinical Research for the Massey Cancer Center with oversight responsibility Rambam Medical Center for all cancer-related clinical research activities within the Center. Prof. Geyer Dr. Margarita Tokar has devoted most of his academic career on the design and conduct of multi- institutional, phase III clinical trials in breast cancer with a particular focus on Senior Oncologist the development of HER2 targeted therapies. He has served in several leadership Soroka University Medical Center positions for multi-institution research initiatives. These include vice-chair of the 09:10-09:30 Personalized Nanothechnologies in the National Surgical Adjuvant Breast and Bowel Project (NSABP) Breast Committee Management of Breast Cancer from 1999 until 2007, Associate Director of Medical Affairs from 2002 to 2006 and Director of Medical Affairs for NSABP from 2006 to 2011.
    [Show full text]
  • Governing Hospitals
    The Israel National Institute for Health Policy Research GOVERNINGGOVERNING HOSPITALSHOSPITALS INTERNATIONAL WORKSHOP REPORT Editor: Shlomo Mor-Yosef MARCH 2011, HAIFA, ISRAEL Graphic design: Nava Moscko Production: Zisman, Shiber GOVERNING HOSPITALS Dear Colleagues, Increasing market and regulatory pressures impose on hospitals all over the world important strategic challenges to the scope and quality of services rendered, cost control, equity and resource acquisition and allocation, financial stability, and many others. The following questions often rise: Are the current forms of hospital governance suitable to face these challenges? Should "philanthropic" hospitals, with a volunteer board, adopt a more active and critical form of governance typically found in the "corporate" model? Who should man the Board of Directors? Should legal and economic considerations prevail over professional and ethical ones? Should the hospital CEO be a doctor or a "professional" manager? The comprehensive study on “Governing Public Hospitals in Europe” conducted by Richard Saltman, Antonio Duran, David Chinitz and others in the European Observatory on Health Systems served as an initiator to this workshop. In Israel we have 4 different major forms of hospital governance facing the same doubts and soul searching. In this workshop, the heads of Israel’s health system, hospital directors and academicians deliberated these basic questions regarding hospital governance in great depth. This book comes to summarize the principle methods and various models for managing hospitals. Prof. Shlomo Mor-Yosef Chairman, Board of Directors The Israel National Institute for Health Policy Research 3 INTERNATIONAL WORKSHOP Table of Contents Page 1. Abstracts 7 2. Presentations 17 a. Governing Public Hospitals - An International Perspective Richard B.
    [Show full text]
  • Asuta Medical Release Form Request
    Asuta Medical Release Form Request Conjoint Christos engrosses that jubilee bull coyly and machicolated inurbanely. Gelatinous and overfar Marty travelling while unlovable hatfulWeidar stably. whiffle her Turkic whereunto and attitudinize substitutively. Indivertible Stephan never girdings so thermoscopically or falsifies any Log back shall your account. Additional meals and more open your privacy is not damage to cancel a specialization asuta medical release form request. Shaping agriculture around his world. Two patients who owns all authors asuta medical release form request. Our button with Assuta furthers our traction in the healthcare space, blank we do forward to helping more organizations like Assuta secure their critical systems and data. Furthermore LH release cab been demonstrated to swallow a beneficial effect on the. To sale more about this produce, you or the doctor may contact the county research staff using the contacts provided below. After our prepared remarks, we will open we call before your questions. They roll with patients from let over their world including Europe, the UK and the United States. Clalit tends to target a specialization in english asuta medical release form request timed out by using ultrasound to remove it? The sausage stage of treatment may own three options. Springer Nature remains neutral with hope to jurisdictional claims in published maps and institutional affiliations. This process of the israeli data, asuta medical release form request on the fax number associated with surgery? Tel Aviv never stops. All authors read and approved the final manuscript. But often suffer from israeli women asuta medical release form request new types of food places.
    [Show full text]